MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202521079217 A) filed by Pawan Shrimal, Bhopal, Madhya Pradesh, on Aug. 21, 2025, for 'a non-aqueous suspension of clobetasol which is ready to use topically and systemically.'
Inventor(s) include Vinay Shankar Tripathi; Shwetank Shrimal; and Akshay Nikhil Patel.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "Disclosed are parenteral pharmaceutical drug products with Clobetasol as the active pharmaceutical ingredient with acceptable onset of action, duration of action and AUC. Also, this formulation will have superior patient compliance, metabolism and elimination."
Disclaimer: Curated by HT Syndication.